Information on Tirzepatide Peptide Once Weekly Diet Shot

​

RevIVeU is now offering Tirzepatide in our weight loss clinics. Tirzepatide is the active ingredient in Mounjaro, an FDA-approved medication for the treatment of diabetes. Tirzepatide is a peptide that is used off-label as a weekly diet injection until it is expected to receive FDA approval for weight loss later in 2023 or 2024.  Phase III clinical studies demonstrate a 50% increase in bodyweight reduction in Tirzepatide vs. Semaglutide in a 52-week period, with similar side effects.  

​

As the first to be a dual GIP/GLP-1 receptor co-agonist, Tirzepatide is stronger in controlling blood sugar levels and acts as a potent appetite suppressant by reducing feelings of hunger while increasing satiety even with reduced food intake.  

​

Phase III studies seeking FDA approval for weight loss demonstrate a Tirzepatide 22.5% reduction in body weight compared to a 15% bodyweight reduction by that of semaglutide, with comparable side effects.

​

Patients can choose to receive Tirzepatide for only 1-week Tirzepatide 2.5mg as a trial for $130. Please be advised that Tirzepatide is dose-dependent upon the duration of use; meaning the longer you use it, the higher your dose may be, up to 15mg/week, the more effective Tirzepatide can be. However, most patients tend to stay at or below 10mg.

Tirzepatide Weekly Peptide Diet Shots

Tirzepatide weekly peptide diet injection should be kept in the refrigerator. Please be advised that Tirzepatide is dose-dependent upon the duration of use; meaning the longer you use it, the higher your dose will be with a max dose of 15 mg a week. Therefore, the price will increase as your dose is adjusted and increased by a licensed medical professional. If you miss 14 consecutive days, without an injection, you will need to restart at the starting dose (2.5 mg).

 

Step-Up Dosing for Tirzepatide Peptide Diet Shots

 

2.5 mg (7 days) $130

One week trial tirzepatide 2.5 mg: $130

​

7.5  or 10 mg (30 days): $650

Third month (4 weeks) tirzepatide 7.5 mg: $650

Fourth month (4 weeks) tirzepatide 10 mg: $650

​

2.5 or 5 mg (30 days) $450 

First month (4 weeks) tirzepatide 2.5 mg: $400

Second month (4 weeks) tirzepatide 5 mg: $450

​

12.5 or 15 mg (30 days) $850

Fifth month* (4 weeks) tirzepatide 12.5 mg: $850

Sixth month onward* (4 weeks) tirzepatide 15 mg: $850 

 

*Not all patients will require this final increase to see desired results

Patients who have a history or diagnosis of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 (MEN II) are not eligible to receive semaglutide/tizepatide